The Royal Pharmaceutical Society has designated four pharmacists in Scotland as its fellows in recognition of their services to the profession.
Pharmacists Paul Forsyth, Alasdair MacIntryre and Peter Mulholland were presented with their certificates at a recent celebration and networking evening at RPS
Scotland's building on Melville Street, Edinburgh, while the fellowship of the fourth pharmacist, Findlay Hickey, will be celebrated in 2023.
The evening also saw RPS Scotland director Clare Morrison and General Pharmaceutical Council Scotland director Laura Fulton welcome a group of newly qualified
pharmacists to the profession.
Commenting on the evening's celebration, Morrison said: "It was an absolute pleasure to welcome pharmacists to our building in Edinburgh, the home of pharmacy in
Scotland. The mood was so vibrant as people came together to celebrate and to network.
The UK's Health Security Agency (UKHSA) said mistakes at a testing laboratory led to misreporting of tens of thousands of positive COVID-19 cases as negative
and may have resulted in the deaths of about 20 people.
Britain has one of the highest coronavirus death tolls in the world, with more than 177,000 deaths since the pandemic started in 2020.
Many experts have said the contact tracing programme fell well short of the "world-beating" system the government had promised.
An investigation by the government agency responsible for responding to public health emergencies said the Immensa laboratory in central England was found to have
misreported around 39,000 tests as negative when they should have been positive between September 2 and October 12 last year.
Lapses in strategies to tackle COVID-19 this year continue to create the perfect conditions for a deadly new variant to emerge, as parts of China witness a
rise in infections, the head of the World Health Organization said on Friday (December 2).
The comments by WHO Director-General Tedros Adhanom Ghebreyesus mark a change in tone just months after he said that the world has never been in a better position
to end the pandemic.
"We are much closer to being able to say that the emergency phase of the pandemic is over, but we're not there yet," Tedros said on Friday.
The global health agency estimates that about 90% of the world's population now has some level of immunity to SARS-COV-2 either due to prior infection or vaccination.
"Gaps in testing … and vaccination are continuing to create the perfect conditions for a new variant of concern to emerge that could cause significant mortality,"
Tedros said.
COVID-19 infections are at record highs in China and have started to rise in parts of Britain after months of decline.
Well Pharmacy has announced a new partnership with RangeMe, a product discovery, sourcing and purchasing platform, as it looks to increase the diversity of
products available to its customers.
The independent pharmacy chain said the partnership will provide new, emerging and diverse brands increased access to its buying teams. There are already over
200,000 suppliers registered on the RangeMe platform.
"We pride ourselves on being at the heart of the communities we serve and are delighted to be working with RangeMe to increase the diversity of the products we
are able to offer to our customers across the UK," Reena Takhar, head of OTC & NHS buying at Well Pharmacy said.
"Given the ongoing cost-of-living crisis, we're keen to do all we can to give businesses of all sizes the opportunity to connect with our buyersto allow us to
offer new and interesting great value products to our customers."
RangeMe helps retailers and their buying teams scale product sourcing efforts with streamlined submissions, simplified discovery tools, and the industry standard
digital sell sheet.
As we transition in England through yet another NHS organisational change, I ask myself what does this mean for community pharmacy? I would like to think that
this change will bring about opportunity and a chance for community pharmacy to showcase and continue the excellent work that was carried out during the height of
the pandemic and is still ongoing today.
I hope that it allows community pharmacy to be regarded as part of the NHS rather than sitting on the side lines. This change has to lead to better funding for
community pharmacy, without sufficient funding we will see more pharmacies close.
We are hearing a lot about winter pressures but this year it feels like all year round pressure. What I have seen, whilst the NHS is under such pressure, is North
East London (NEL) CCG transitioning to an integrated care board (ICB) almost seamlessly.
I have seen people transitioning into new roles, whilst working hard to ensure that all plates are still spinning, which at the moment is no mean feat. I spent a
day out recently visiting pharmacies with the chief medical officer of NHS NEL, Dr Paul Gilluley.
The visits were positive, we felt listened to and understood. The feedback was great, it was recognised that community pharmacy is often the informal front door to
the NHS and that we have so much to offer in terms of ill health prevention.
Community pharmacy can offer a total solution as long as we have the tools to do so, which can save so much time and money. An example is the GP CPCS service, which
has launched well across NEL.
Welsh First Minister Mark Drakeford joined Diwali celebration at the official Indian government in Cardiff on 26 October.
The 68-year-old Labour politician joined in with the traditional Indian dancing at Glamorgan Cricket club in Pontcanna, Cardiff, for the Hindu celebration of Diwali.
He was joined by Health Minister Baroness Eluned Morgan and Indian Honorary Consul Raj Aggarwal, who organised the event which was attended by hundreds of guests and
included some exuberant celebrations.
Speaking at the event Raj Aggarwal spoke about the excitement in the British Asian community to have the UK's first ever Asian Prime Minister.
The Royal Pharmaceutical Society (RPS) has launched a new position paper on 'How pharmacy can do more to tackle health inequalities'.
The RPS paper aims to help pharmacists and pharmacy teams to take action against health inequalities. It is designed to provide a reference source for pharmacy
teams to use over time to continually improve services.
RPS said: "Like all health services, these pharmacy services do not always reach everyone. Often it is people who are suffering the greatest inequalities that find
it most difficult to access the services that are currently available. This can be for a large number of reasons including poverty, education, being part of a group
vulnerable to exclusion, language and power."
Therefore, the RPS paper focuses not on "what" services pharmacy provides but "how" they are provided, with an aim of making them more accessible for people who are
currently struggling.
Claire Anderson, President of Royal Pharmaceutical Society said: "It's fantastic that pharmacy teams in every sector of pharmacy across Great Britain are providing
care that can improve health inequalities, with many patients able to access pharmacy services very easily. Brilliant examples of this shine through in the paper.
A community pharmacist who supplied a drug addict with "under the counter drugs" has been jailed for 18 months.
Dushyant Patel, 67, a London pharmacist with more than 40 years' experience, had supplied class C drugs to a drug user in Norwich for months in 2020.
Police identified Patel as a suspect four months after the death of drug user, Alisha Siddiqi, whose body was found at a property in Colossus Way, Costessey, in
August 2020.
An initial post-mortem examination was inconclusive, but toxicology results later showed she died from an overdose of prescription medication.
An analysis of her phone revealed that she had frequent communication with Patel between January and August 2020.
Class C drugs sold without prescription
There was also communication regarding transactions relating to the sale of prescription drugs including class C drugs, without a prescription, namely Zolpidem and
Zopiclone.
Patel was identified as a suspect and later charged with drugs offences.
He was jailed at Norwich Crown Court in December after a trial in August when he was found guilty of two counts of being concerned in supplying a controlled drug
between March and August 2020.
Moderna has joined one of the UK's leading pharmaceutical industry body, Association of the British Pharmaceutical Industry (ABPI) to expand its footprint and
investment in the UK.
The biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines will strengthen its footprint with the new state-of-the-art vaccine research,
development and manufacturing facility in the UK. It will create valuable new jobs and build on the strength of the UK's life sciences ecosystem.
The company is best known for their work during the COVID-19 pandemic and are now developing a range of mRNA-based vaccines for a number of conditions.
The ABPI represents companies of all sizes who invest in discovering the medicines of the future, including some of the world's largest, most innovative, and most
successful pharmaceutical firms.
Darius Hughes, UK General Manager, Moderna, said: "We are delighted to join the ABPI - this alliance is an important part of our long-term commitment to the UK and
supports the wider significant investments in manufacturing, research and development we are making in this country.
Teva UK has begun replacing its existing packaging with a new design which is "clearer and easier to read".
The new look is "unique, recognisable and distinctive." It "enhances safety and provides a recognisable and distinguishable pack range."
One of the UK's leading generics manufacturers, Teva UK supplies more than 500 generic pharmaceutical products to retail and hospital pharmacies.
The company says each product within the portfolio is distinguishable by colour, ensuring no two different packs have the same drug and strength colours and with
additional product information on the side of the pack and a simplified back, it makes it even easier to identify the correct product when dispensing and supports
patients when taking their medication.
"Our medicines impact the lives of millions of people every day and our packaging is often the first touchpoint for our patients and our customers", said Kim Innes,
general manager of Teva UK and Ireland.
The Royal Pharmaceutical Society (RPS) has appointed Laura Wilson as Director for Scotland commencing 23rd January 2023.
Laura, is currently Policy and Practice Lead for RPS in Scotland. She is accountable for bringing national RPS policy to life for members in Scotland, while
contributing to the GB wide professional leadership agenda.
She will work closely with the Scottish Pharmacy Board, senior NHS officials and other key stakeholders across the breadth of the pharmacy profession and beyond
to ensure pharmacy is on the forefront of healthcare in Scotland.
She joins the existing team of RPS Country Directors, which includes Elen Jones, Director for Wales and James Davies, Director for England and will report directly
to the Chief Executive.
Laura Wilson said: "I am delighted to be appointed Director for Scotland having worked as part of the RPS Scotland team as the policy and practice lead. It will
be an honour to continue the fantastic work started by former Director Clare Morrison to bring Pharmacy 2030, our vision for pharmacy in Scotland in the future,
to life and supporting pharmacy teams to deliver person centred care.
Will Quince, MP for Colchester and Health Minister visited Rowlands pharmacy on Friday (20 January) in Nayland Road in his constituency.
The important role played by pharmacies in providing NHS care, support, and advice helping the local community to live healthier lives and manage long-term conditions
were discussed among the pharmacy teams.
Mr Quince said: "Community pharmacy is playing an increasingly important role in ensuring people in Colchester have convenient walk-in access to the healthcare
support and advice they need.
Pharmacies are not simply places to collect prescriptions, they provide a wide range of services and are the third pillar of access to primary care alongside GPs and
A&E. I would urge people to think pharmacy first if they have a minor ailment; need advice on taking their medication; want to stop smoking or want to check their
blood pressure."
Jeremy Meader has resigned as managing director of Numark after five years on the job, and having lead the wider PHOENIX group's sales and marketing teams for
about eight years.
A press release issued on Wednesday (February 1) said Mr Meader "has decided to leave the business to pursue his career outside of the PHOENIX group", the owner of
Numark.
It said: "PHOENIX thanks Jeremy for his commitment and dedication over the years and wishes him all the best for his professional and private future."
Previous to joining PHOENIX, Mr Meader was head of sales at Alliance Healthcare, a role he took up in 2012 after serving GSK's Consumer Healthcare division for over
13 years in various capacity.
Perrigo, one of the world's largest providers of self-care products has appointed Ronald van Workum as Sales Director Germany, Customer Strategy & Implementation
DACH Cluster.
van Workum will continue to drive the successful integration of HRA Pharma into the Perrigo network, with a focus on well-known brands such as Abtei, Compeed and
Granu Fink.
He most recently held the position of Head of Key Account Management for Perrigo in Europe, based in the Netherlands. Prior to joining Perrigo he worked for Procter
& Gamble in several countries, including Singapore, and in various functions, including: Market Strategy Planning Manager for the Gillette brand; and in Europe as
multifunctional Team Leader Emerging Channels.
The company also announced Tobias Geiger has been promoted from his role as Finance Director of the Perrigo DACH Cluster, which he held since April 2020, to General
Manager of the Perrigo DACH Cluster. During this time, he successfully supported the implementation and stabilisation of the DACH cluster. He also led several
business optimisations with his teams, such as the implementation of SAP in Switzerland, process digitalisation and the creation of a DACH Finance Business Partner
Model. Before joining Perrigo, Geiger worked for Sanofi for more than 10 years in various leadership positions in DACH and in Latin America.
Sun Pharmaceutical Industries, India's largest drugmaker by revenue, reported a better-than-expected 5.2 per cent rise in third-quarter profit on Tuesday,
driven by higher sales of its specialty drugs.
The company, known for its consumer healthcare products such as Revital vitamins and pain relief medicine Volini, said it earned a consolidated net profit of 21.66
billion rupees ($265.23 million) in three months ended Dec. 31, up from 20.59 billion rupees last year.
Analysts, on average, had expected the company to report a profit of 21.26 billion rupees, according to Refinitiv IBES data.
Total revenue from operations climbed nearly 14 per cent to 112.41 billion rupees. Input costs rose 8.5 per cent. Drug sales in India rose 7.1 per cent to 33.92
billion rupees, whereas sales in the United States climbed 16.6 per cent to 34.66 billion rupees, with each of the two regions accounting for 31 per cent of the
company's total consolidated sales.
The company, founded in 1983, makes over-the-counter medications, anti-retrovirals and active pharmaceutical ingredients for chronic and acute treatments.
Jonathan Burton will receive the 2022 RPS Charter Award for his outstanding work for the Society and the wider profession in promoting the interests of pharmacy.
The award will be presented by the President at a future meeting of Fellows and Members to take place at the Society's Edinburgh office on 22nd March 2023.
Jonathan's main role is as a practising, patient-facing pharmacist within the community in NHS Forth Valley where he uses his advanced practice skills and independent
prescribing qualification to assess and treat acute ENT, dermatology, and respiratory conditions.
He was one of the first community pharmacist prescribers in Scotland and has always been at the forefront of innovation and service development.
Jonathan has demonstrated outstanding commitment and passion for the pharmacy profession throughout his career. He has excelled as a pharmacist in the Right Medicine
Pharmacy group, on local and national committees, in advocacy for the pharmacy profession and as a local and national leader who is highly regarded as an exceptional
role model for the profession.
The Association of the British Pharmaceutical Industry (ABPI) has announced that Pinder Sahota has decided to step down as President of the ABPI.
ABPI stated that he has made this decision to "avoid an ongoing process around a Novo Nordisk ABPI Code of Practice breach becoming a distraction from the vital
work of the ABPI".
Richard Torbett, Chief Executive, ABPI, said: "Pinder is a passionate advocate for the industry, and I want to thank him for his valuable contribution as ABPI
President.
"I fully respect Pinder's decision to step down as ABPI President which will in no way affect the ongoing case relating to Novo Nordisk. Any breach of the ABPI
Code is taken extremely seriously and it is essential that all regulatory actions are robust, fair and transparent."
ABPI Vice-President, Susan Rienow, Country President of Pfizer, will temporarily take on the roles and responsibilities of the ABPI President until a new President
is chosen by the ABPI Board.
Boehringer Ingelheim UK & Ireland has appointed Vani Manja as its new Country Managing Director and Head of Human Pharma.
Manja has been associated with Boehringer Ingelheim for over 11 years, in successful leadership roles in Germany, the United States and most recently as General
Manager, India.
Her career started as a commissioned officer in the Indian Army Ordnance Corps which preceded leadership roles at Becton Dickinson and McKinsey.
She brings extensive experience of strategy, marketing, sales, business development, people management, and cultural transformation and is passionate about tackling
healthcare inequalities and advancing sustainable healthcare.
Commenting on her new role, Manja said: "It is with great heart that I bring the spirit of conscious leadership to my new role. I look forward to being fully present
and partnering with key stakeholders in the healthcare ecosystem in our collective quest to improve health for humans and animals in the UK and Ireland."
The Pharmaceutical Services Negotiating Committee (PSNC) has urged community pharmacy to plan and ensure patients are able to access their prescription if they
have to close in an emergency situation for a short period.
It has prepared a guidance which can be undertaken by pharmacy in the event of a closure and the contractor's business can resume easily and effectively once the
emergency has passed.
In its guidance, PSNC has stated a few actions that can be taken by pharmacy in advance:
Plan ahead - be ready before a closure is needed. Don't wait until your pharmacy needs to be closed before you consider how you will manage and what you can put in
place to mitigate the impact.
Make sure your business continuity plan is up to date and relevant to the current situation. For example, try not to rely on family and friends as part of your plan;
if you're having to isolate because of infectious illness, your close contacts may need to do so as well.
Ensure your SOPs are accurate, up to date and easy-to-find for someone completely unfamiliar with your pharmacy. Emergency numbers will be crucial. Normal, everyday
business continuity issues are still going to arise and anyone on-site needs to know how to address them:
The Pharmaceutical Services Negotiating Committee (PSNC) has appointed Robbie Turner as chief transformation officer, to work closely with LPCs as part of its
newly launched Transforming Pharmacy Representation (TAPR) programme.
PSNC launched the TAPR Programme in response to the contractor vote in favour of the Review Steering Group's proposals. As part of the programme - alongside
actioning the recommendations for PSNC - there will be support for LPCs to implement their proposals.
Williams will be responsible for leading, driving, and having oversight of the TAPR workstream to increase efficiency and outcomes across the network of LPCs in
England.
This will include the provision of specialist hands-on guidance and support to LPC members and officers, to promote implementation of the RSG proposals, best
practice and challenging the status quo.
Williams was formerly chief officer of Community Pharmacy West Yorkshire LPC and subsequently Director for England and Director of Pharmacy and Member Experience
at the Royal Pharmaceutical Society.